1. Home
  2. KOSS vs ATRA Comparison

KOSS vs ATRA Comparison

Compare KOSS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • ATRA
  • Stock Information
  • Founded
  • KOSS 1953
  • ATRA 2012
  • Country
  • KOSS United States
  • ATRA United States
  • Employees
  • KOSS N/A
  • ATRA N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KOSS Consumer Staples
  • ATRA Health Care
  • Exchange
  • KOSS Nasdaq
  • ATRA Nasdaq
  • Market Cap
  • KOSS 81.3M
  • ATRA 54.0M
  • IPO Year
  • KOSS N/A
  • ATRA 2014
  • Fundamental
  • Price
  • KOSS $9.15
  • ATRA $10.43
  • Analyst Decision
  • KOSS
  • ATRA Hold
  • Analyst Count
  • KOSS 0
  • ATRA 7
  • Target Price
  • KOSS N/A
  • ATRA $150.70
  • AVG Volume (30 Days)
  • KOSS 9.1M
  • ATRA 121.2K
  • Earning Date
  • KOSS 08-22-2024
  • ATRA 08-06-2024
  • Dividend Yield
  • KOSS N/A
  • ATRA N/A
  • EPS Growth
  • KOSS N/A
  • ATRA N/A
  • EPS
  • KOSS N/A
  • ATRA N/A
  • Revenue
  • KOSS $12,475,699.00
  • ATRA $34,704,000.00
  • Revenue This Year
  • KOSS N/A
  • ATRA $1,220.54
  • Revenue Next Year
  • KOSS N/A
  • ATRA N/A
  • P/E Ratio
  • KOSS N/A
  • ATRA N/A
  • Revenue Growth
  • KOSS N/A
  • ATRA N/A
  • 52 Week Low
  • KOSS $2.27
  • ATRA $4.98
  • 52 Week High
  • KOSS $18.73
  • ATRA $63.38
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 58.56
  • ATRA 49.23
  • Support Level
  • KOSS $8.81
  • ATRA $9.81
  • Resistance Level
  • KOSS $11.84
  • ATRA $12.98
  • Average True Range (ATR)
  • KOSS 2.79
  • ATRA 1.28
  • MACD
  • KOSS -0.06
  • ATRA 0.36
  • Stochastic Oscillator
  • KOSS 30.27
  • ATRA 55.03

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: